Genomics

RSS

Genetic analysis suggests the sudden emergence of threatening viruses

Suddenly they appear and - like the SARS-CoV-2 coronavirus - can trigger major epidemics: Viruses that nobody had on their radar.

13 May 2024

ERS Genomics appoints John E Milad as Chief Executive Officer

ERS Genomics Limited (‘ERS’), the CRISPR licensing company, today announced the appointment of John E Milad as CEO, with immediate effect. John brings over 25 years of experience as an executive leader, venture capitalist, and investment banker focused on the life sciences and medical technology sectors.

From ERS Genomics 13 May 2024

Exploring the relationship between evolvability and species divergence

Ever since Darwin published his landmark theory of how species evolve, biologists have been fascinated with the intricate mechanisms that make evolution possible.

10 May 2024

Identification of pathogenicity-associated milRNAs in Fusarium oxysporum f. sp. cubense

Fusarium oxysporum f. sp. cubense (Foc) is a typical soil-borne fungus that causes Fusarium wilt by infecting the roots and blocking the vascular tissues of host banana, and threatens the global banana production.

10 May 2024

New modular epigenome editing platform sheds light on gene regulation mechanisms

Understanding how genes are regulated at the molecular level is a central challenge in modern biology.

9 May 2024

Gene linked to intellectual disability can regulate learning and memory

A gene previously linked to intellectual disability has been found to regulate learning and memory in mice.

8 May 2024

Study uncovers genetic link between height growth during puberty and long-term health in adulthood

A genetic link between height growth during puberty and long-term health in adulthood has been identified by a new study from the University of Surrey and the University of Pennsylvania.

7 May 2024

Rutgers scientists create CRISPR-edited mice to study the neurobiology of Tourette disorder

In research that may be a step forward toward finding personalized treatments for Tourette disorder, scientists at Rutgers University–New Brunswick have bred mice that exhibit some of the same behaviors and brain abnormalities seen in humans with the disorder.

6 May 2024

CRISPR gene editing shows promise for treating individuals with a form of inherited blindness

Results from a groundbreaking clinical trial of CRISPR gene editing in 14 individuals with a form of inherited blindness show that the treatment is safe and led to measurable improvements in 11 of the participants treated.

6 May 2024

Genomics plc and GSK collaborate to harness polygenic risk scores in clinical trials

Genomics plc and GSK announced a new collaboration to explore the potential for using polygenic risk scores (PRS) in clinical trials, to improve understanding of disease risk and patient selection, which could support optimization of trial design.

6 May 2024

GenE-HumDi's strategy for involving young scientists in cutting-edge research

COST Actions are meant to be inclusive which means ensuring a geographic spread of participants, encouraging gender balance, and involving young researchers.

3 May 2024

Researchers map early genetic development of the brain

In an article published in Nature, researchers from Karolinska Institutet present an atlas of the early development of the brain.

3 May 2024

Study uncovers causal genetic variant strongly associated with childhood obesity

Researchers from Children's Hospital of Philadelphia (CHOP) have identified a causal genetic variant strongly associated with childhood obesity.

2 May 2024

Healthy lifestyle may offset genetic risks for early death, study finds

Study found that both lifestyle and genetic factors independently influence lifespan, but a healthy lifestyle can reduce the impact of genetic predispositions toward a shorter life.

1 May 2024

Garvan Institute and Illumina collaborate to transform the treatment of complex diseases

Illumina, a global genomics and human health company, has partnered with the Garvan Institute of Medical Research's TenK10K project to help transform the treatment of complex diseases, starting with autoimmune diseases, with a joint investment of $27 million AUD.

30 Apr 2024

Genomics

Genetic analysis suggests the sudden emergence of threatening viruses

ERS Genomics appoints John E Milad as Chief Executive Officer

Exploring the relationship between evolvability and species divergence

Identification of pathogenicity-associated milRNAs in Fusarium oxysporum f. sp. cubense

New modular epigenome editing platform sheds light on gene regulation mechanisms

Gene linked to intellectual disability can regulate learning and memory

Study uncovers genetic link between height growth during puberty and long-term health in adulthood

Rutgers scientists create CRISPR-edited mice to study the neurobiology of Tourette disorder

CRISPR gene editing shows promise for treating individuals with a form of inherited blindness

Genomics plc and GSK collaborate to harness polygenic risk scores in clinical trials

GenE-HumDi's strategy for involving young scientists in cutting-edge research

Researchers map early genetic development of the brain

Study uncovers causal genetic variant strongly associated with childhood obesity

Healthy lifestyle may offset genetic risks for early death, study finds

Garvan Institute and Illumina collaborate to transform the treatment of complex diseases

Groundbreaking study reveals over 100 new genomic regions linked to blood pressure

AI-MARRVEL: A leap forward in diagnosing genetic diseases with over 98% precision

RNA editing using CRISPRs shows promise for genetic disease treatment

Study reveals genetic divergence and drug resistance mechanisms in two critical superbugs

Genetic associations of key genes in breast cancer pathogenesis

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest Life Science News